-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Mereo BioPharma Group plc quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
- Mereo BioPharma Group plc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $8,329,000, a 4.2% decline year-over-year.
- Mereo BioPharma Group plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was $32,834,000, a 55% decline from 2023.
- Mereo BioPharma Group plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $21,132,000, a 57% increase from 2022.